Form 8-K Astrana Health, Inc. For: Feb 26

Go back to Form 8-K Astrana Health, Inc. For: Feb 26

Astrana Health, Inc (ASTH) PT Lowered to $49 at BofA Securities

March 3, 2025 1:40 PM EST

BofA Securities analyst Adam ROn lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $49.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "ASTH reported somewhat mixed 4Q results. Despite roughly hitting consensus EBITDA estimates, the company missed its... More